Ubrelvy (ubrogepant) is a prescription oral tablet that’s used for fast-acting relief of migraine symptoms in adults. Ubrelvy may not be safe to take while pregnant or breastfeeding. If you can ...

Eli Lilly has a battle on its hands in the migraine prevention category with third-to-market CGRP inhibitor Emgality but could get a leg-up with an indication in episodic cluster headache.

IN 30 YEARS, THE CITY HAS DISTRIBUTED MORE THAN. 17.6 MILLION SYRINGES, AND WE STAND IN SOLIDARITY WITH THOSE WHO ARE STRUGGLING WITH ADDICTION. WHILE HONORING MISUSERS WHO LOST THEIR LIVES.

Organon and Eli Lilly and Company have broadened their commercial agreement under which the former will be the sole distributor and promoter of the migraine medication Emgality (galcanezumab ...

JERSEY CITY, N.J. - Organon (NYSE: OGN), a company dedicated to women's health, has broadened its distribution agreement with Eli Lilly and Company (NYSE:LLY) for the migraine medication Emgality ...

Eli Lilly’s third-to-market migraine prevention drug Emgality has a lot of ground to make up on its rivals, but a new study in people who have failed earlier migraine therapies could help.